These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25542792)

  • 1. Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.
    Schneider CS; Perez JG; Cheng E; Zhang C; Mastorakos P; Hanes J; Winkles JA; Woodworth GF; Kim AJ
    Biomaterials; 2015 Feb; 42():42-51. PubMed ID: 25542792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.
    Wadajkar AS; Dancy JG; Roberts NB; Connolly NP; Strickland DK; Winkles JA; Woodworth GF; Kim AJ
    J Control Release; 2017 Dec; 267():144-153. PubMed ID: 28887134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells.
    Carney CP; Pandey N; Kapur A; Saadi H; Ong HL; Chen C; Winkles JA; Woodworth GF; Kim AJ
    ACS Nano; 2023 Oct; 17(20):19667-19684. PubMed ID: 37812740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.
    Zhou H; Marks JW; Hittelman WN; Yagita H; Cheung LH; Rosenblum MG; Winkles JA
    Mol Cancer Ther; 2011 Jul; 10(7):1276-88. PubMed ID: 21586630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.
    Gu G; Xia H; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Chen H; Gao X; Chen J
    Biomaterials; 2013 Jan; 34(1):196-208. PubMed ID: 23069707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fn14-targeted BiTE and CAR-T cells demonstrate potent preclinical activity against glioblastoma.
    Li G; Zhang Z; Cai L; Tang X; Huang J; Yu L; Wang G; Zhong K; Cao Y; Liu C; Wang Y; Tong A; Zhou L
    Oncoimmunology; 2021; 10(1):1983306. PubMed ID: 34595061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
    Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
    Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Strategy Utilizing Extracellular Cysteine-Rich Domain of Membrane Receptor for Constructing d-Peptide Mediated Targeted Drug Delivery Systems: A Case Study on Fn14.
    Li Z; Xie J; Peng S; Liu S; Wang Y; Lu W; Shen J; Li C
    Bioconjug Chem; 2017 Aug; 28(8):2167-2179. PubMed ID: 28715634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model.
    Stephen ZR; Chiarelli PA; Revia RA; Wang K; Kievit F; Dayringer C; Jeon M; Ellenbogen R; Zhang M
    Cancer Res; 2019 Sep; 79(18):4776-4786. PubMed ID: 31331912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
    Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
    J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-guided nanoparticles for glioblastoma targeting.
    Säälik P; Lingasamy P; Toome K; Mastandrea I; Rousso-Noori L; Tobi A; Simón-Gracia L; Hunt H; Paiste P; Kotamraju VR; Bergers G; Asser T; Rätsep T; Ruoslahti E; Bjerkvig R; Friedmann-Morvinski D; Teesalu T
    J Control Release; 2019 Aug; 308():109-118. PubMed ID: 31255690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles: Implications for Tissue Binding and Tumor Penetration.
    Wadajkar AS; Dancy JG; Carney CP; Hampton BS; Ames HM; Winkles JA; Woodworth GF; Kim AJ
    Nanomedicine; 2019 Aug; 20():102024. PubMed ID: 31176045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.
    Wadajkar AS; Dancy JG; Hersh DS; Anastasiadis P; Tran NL; Woodworth GF; Winkles JA; Kim AJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27813323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
    Strohbehn G; Coman D; Han L; Ragheb RR; Fahmy TM; Huttner AJ; Hyder F; Piepmeier JM; Saltzman WM; Zhou J
    J Neurooncol; 2015 Feb; 121(3):441-9. PubMed ID: 25403507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.